share_log

Oppenheimer Maintains Perform on Marinus Pharma, Maintains $9 Price Target

Moomoo 24/7 ·  Mar 7 08:04

Oppenheimer analyst Jay Olson maintains Marinus Pharma (NASDAQ:MRNS) with a Perform and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment